Together with the data described above, our results demonstrated that REV-ERBα function is reprogrammed in prostate cancer progression from activating tumorigenic kinase signaling and metabolic programs in adenocarcinoma to activating LP gene programs in NEPC. The gene discussed is NR1D1; the disease is prostate cancer.